Noncommunicable diseases and mental health

About 25 indicators of the Global monitoring framework on NCDs

The "Global monitoring framework on NCDs" includes 25 indicators to track the implementation of the action plan through monitoring and reporting on the attainment of the voluntary global targets in 2015 and 2020. The action plan is not limited in scope to the global monitoring framework.

Definition indicators

Indicator 1

Unconditional probability of dying between ages of 30 and 70 from cardiovascular diseases, cancer, diabetes or chronic respiratory diseases

Indicator 2

Cancer incidence, by type of cancer, per 100 000 population

Indicator 3

Total (recorded and unrecorded) alcohol per capita (aged 15+ years old) consumption within a calendar year in litres of pure alcohol, as appropriate, within the national context

Indicator 4

Age-standardized prevalence of heavy episodic drinking among adolescents and adults, as appropriate, within the national context

Indicator 5

Alcohol-related morbidity and mortality among adolescents and adults, as appropriate, within the national context

Indicator 6

Prevalence of insufficiently physically active adolescents, defined as less than 60 minutes of moderate to vigorous intensity activity daily

Indicator 7

Age-standardized prevalence of insufficiently physically active persons aged 18+ years (defined as less than 150 minutes of moderate-intensity activity per week, or equivalent)

Indicator 8

Age-standardized mean population intake of salt (sodium chloride) per day in grams in persons aged 18+ years

Indicator 9

Prevalence of current tobacco use among adolescents

Indicator 10

Age-standardized prevalence of current tobacco use among persons aged 18+ years

Indicator 11

Age-standardized prevalence of raised blood pressure among persons aged 18+ years (defined as systolic blood pressure ≥140 mmHg and/or diastolic blood pressure ≥90 mmHg) and mean systolic blood pressure

Indicator 12

Age-standardized prevalence of raised blood glucose/diabetes among persons aged 18+ years (defined as fasting plasma glucose concentration ≥ 7.0 mmol/l (126 mg/dl) or on medication for raised blood glucose)

Indicator 13

Prevalence of overweight and obesity in adolescents (defined according to the WHO growth reference for school-aged children and adolescents, overweight – one standard deviation body mass index for age and sex, and obese – two standard deviations body mass index for age and sex)

Indicator 14

Age-standardized prevalence of overweight and obesity in persons aged 18+ years (defined as body mass index ≥ 25 kg/m² for overweight and body mass index ≥ 30 kg/m² for obesity)

Indicator 15

Age-standardized mean proportion of total energy intake from saturated fatty acids in persons aged 18+ years

Indicator 16

Age-standardized prevalence of persons (aged 18+ years) consuming less than five total servings (400 grams) of fruit and vegetables per day

Indicator 17

Age-standardized prevalence of raised total cholesterol among persons aged 18+ years (defined as total cholesterol ≥5.0 mmol/l or 190 mg/dl); and mean total cholesterol concentration

Indicator 18

Proportion of eligible persons (defined as aged 40 years and older with a 10-year cardiovascular risk ≥30%, including those with existing cardiovascular disease) receiving drug therapy and counselling (including glycaemic control) to prevent heart attacks and strokes

Indicator 19

Availability and affordability of quality, safe and efficacious essential NCD medicines, including generics, and basic technologies in both public and private facilities

Indicator 20

Access to palliative care assessed by morphine-equivalent consumption of strong opioid analgesics (excluding methadone) per death from cancer

Indicator 21

Adoption of national policies that limit saturated fatty acids and virtually eliminate partially hydrogenated vegetable oils in the food supply, as appropriate, within the national context and national programmes

Indicator 22

Availability, as appropriate, if cost-effective and affordable, of vaccines against human papillomavirus, according to national programmes and policies

Indicator 23

Policies to reduce the impact on children of marketing of foods and non-alcoholic beverages high in saturated fats, trans fatty acids, free sugars, or salt

Indicator 24

Vaccination coverage against hepatitis B virus monitored by number of third doses of Hep-B vaccine (HepB3) administered to infants

Indicator 25

Proportion of women between the ages of 30–49 screened for cervical cancer at least once, or more often, and for lower or higher age groups according to national programmes or policies

Related links

Share